Veera Raghava Chowdary Palacharla

Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease

Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Shinde et al. · European Journal of Medicinal Chemistry · 2015 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1<i>H</i>-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT₆) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease

Ramakrishna Nirogi, Anil Shinde, Rama Sastry Kambhampati et al. · Journal of Medicinal Chemistry · 2017 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays

Ramakrishna Nirogi, Veera Raghava Chowdary Palacharla, Venkatesham Uthukam et al. · Xenobiotica · 2014 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +16

Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study

Ramakrishna Nirogi, John R. Ieni, Vinod Goyal et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2022 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions

Ramakrishna Nirogi, Vishwottam Kandikere, Veera Raghava Chowdary Palacharla et al. · Xenobiotica · 2013 · 29 citations

Medicine, Medicinal Chemistry, Pharmacology +17